Perspective Therapeutic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01 -January 17, 2024 at 08:03 am EST

SEATTLE, Jan. 17, 2024 Perspective Therapeutics, Inc. , today announced that it began patient recruitment for the second dosing cohorts in clinical studies for both of its lead product.

United statesMarkus puhlmannDepartment of energyExchange commissionPerspective therapeutics incChief medical officerPerspective therapeuticMayo clinic rochesterPerspective therapeuticsTransition reportQuarterly report

Perspective Therapeutics, Inc : Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-a-NET and [(212)Pb]VMT01

Perspective Therapeutics, Inc : Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-a-NET and [(212)Pb]VMT01
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesMarkus puhlmannStefan klotterExchange commissionPerspective therapeutics incDepartment of energyChief medical officerPerspective therapeuticMayo clinic rochesterPerspective therapeuticsTransition reportQuarterly reportDie performance strategieAssets sie

Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capability

Lantheus will have the option to negotiate an exclusive license to Perspective Therapeutics’ Pb212-VMT-α-NETLantheus will have the option to co-fund and negotiate an exclusive license for certain.

United statesNew jerseyMary anne heinoThijs spoorPerspective therapeutics incLantheus holdings incDepartment of energyExchange commissionPerspective therapeuticsPerspective therapeuticLantheus holdingsChief executive officerTransition reportQuarterly report

Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics

Option to license Perspective Therapeutics’ Pb212-VMT-α-NET asset Co-development rights for certain Pb212-based alpha therapies for prostate cancer Equity investment of up to 19.9% in.

United statesNew jerseyThijs spoorMark kinarneyMary anne heinoSecurities exchangePerspective therapeutics incLantheus holdings incExchange commissionPerspective therapeuticsChief executive officerPerspective therapeuticPrivate securities litigation reform actSecurities actSecurities exchange actRisk factors

Perspective Therapeutics (CATX) Divests Brachytherapy Business

Perspective Therapeutics (CATX) Divests Brachytherapy Business
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesThijs spoorPerspective therapeutics incGt medical technologies incIsoray medical incPerspective therapeuticsIsoray medicalPerspective therapeuticSurgically targeted radiation therapyGammatile therapy